Preliminary results of blood test to diagnose CTE during life published in Journal of Alzheimer's Disease

Preliminary results of blood test to diagnose CTE during life published in Journal of Alzheimer's Disease:

Dementia Big
Exosome Sciences, Inc., in collaboration with majority shareholder Aethlon Medical, Inc. and investigators at Boston University and the University of Washington, announced today the published preliminary results of possibly the first blood test to detect the neurodegenerative disease, Chronic Traumatic Encephalopathy (CTE) during life.

http://ift.tt/1X6vQH9